Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:1009119-64-5,CAS 1009119-64-5,OVPGYLMBPQNZNE-GJVQWJCYSA-N 1009119-64-5
Conbott Pharmtech Co.,Ltd. 1009119-64-5,CAS 1009119-64-5,OVPGYLMBPQNZNE-GJVQWJCYSA-N 1009119-64-5
Home > Products > Intermediates > Anti-Viral Intermediate > Daclatasvir (BMS-790052) CAS 1009119-64-5
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Daclatasvir (BMS-790052) CAS 1009119-64-5

Share to:  
    Min. Order: 1 Gram

Basic Info

Model No.1009119-64-5

BrandConbottpharm

Additional Info

PackagingAs required

ProductivityCustomized

TransportationAir

Place of OriginChina

Supply AbilityCommercial

CertificateDocuments Support

Product Description

Backed by a team of professional, we are engaged in offering superior quality Daclatasvir CAS 1009119-64-5. Daclatasvir (trade name Daklinza) is also called BMS-790052, BMS 790052, EBP 883. Daclatasvir CAS NO 1009119-64-5 is a first-in-class, highly-selective oral HCV NS5A inhibitor that is a useful drug to treat hepatitis C (HCV). We can offer the goods in proper packaging of diverse quantity to meet the requirements of the customers.

Thera. Category: Anti-VIRAL

Cas No.: 1009119-64-5

Synonym: dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate;diMethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl);Daclatasvir;EBP 883;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester;Daclatasvir/EBP883;daclatavir;BMS-790052(Daclatasvir)

1009119-64-5


Molecular Formula: C40H50N8O6

Molecular Weight: 738.88

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Daclatasvir (BMS-790052) is a highly selective HCV NS5A inhibitor, EC50 of 9-50 pM, in cell culture, to act on a variety of genotypes of HCV replication and JFH-1 genotype 2a infectious virus.

Related Products:

  • 4,4'-Diacetylbipheny, MFCD00017248 CAS 787-69-9
  • 4,4'-Bis(2-bromoacetyl)biphenyl CAS 4072-67-7
  • Boc-Pro-OH, N-Boc-L-Proline CAS 15761-39-4
  • Daclatasvir inter DK N-2 CAS 1007882-23-6
  • 1,2-Pyrrolidinedicarboxylic acid,
  • 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)] ester. CAS 1009119-82-7
  • 1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4) CAS 1009119-83-8
  • Daclatasvir (BMS-790052) CAS 1009119-64-5

Product Categories : Intermediates > Anti-Viral Intermediate

Product Images
  • Daclatasvir (BMS-790052) CAS 1009119-64-5
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2024 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?